AU6927198A - 3-aminopyridine derivatives for treatment of inflammatory and malignant diseases - Google Patents

3-aminopyridine derivatives for treatment of inflammatory and malignant diseases

Info

Publication number
AU6927198A
AU6927198A AU69271/98A AU6927198A AU6927198A AU 6927198 A AU6927198 A AU 6927198A AU 69271/98 A AU69271/98 A AU 69271/98A AU 6927198 A AU6927198 A AU 6927198A AU 6927198 A AU6927198 A AU 6927198A
Authority
AU
Australia
Prior art keywords
inflammatory
treatment
malignant diseases
aminopyridine derivatives
aminopyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU69271/98A
Inventor
Doreen Mary Ashworth
David Michael Evans
Richard Jeremy Franklin
Paul David Jenkins
David Alan Kendrick
Graeme Semple
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferring BV
Original Assignee
Ferring BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring BV filed Critical Ferring BV
Publication of AU6927198A publication Critical patent/AU6927198A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU69271/98A 1997-04-04 1998-04-03 3-aminopyridine derivatives for treatment of inflammatory and malignant diseases Abandoned AU6927198A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9706923A GB2323842A (en) 1997-04-04 1997-04-04 Pyridine derivatives
GB9706923 1997-04-04
PCT/GB1998/000997 WO1998045266A1 (en) 1997-04-04 1998-04-03 3-aminopyridine derivatives for treatment of inflammatory and malignant diseases

Publications (1)

Publication Number Publication Date
AU6927198A true AU6927198A (en) 1998-10-30

Family

ID=10810333

Family Applications (1)

Application Number Title Priority Date Filing Date
AU69271/98A Abandoned AU6927198A (en) 1997-04-04 1998-04-03 3-aminopyridine derivatives for treatment of inflammatory and malignant diseases

Country Status (3)

Country Link
AU (1) AU6927198A (en)
GB (1) GB2323842A (en)
WO (1) WO1998045266A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003276201A1 (en) * 2002-11-11 2004-06-03 Bayer Healthcare Ag Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist
US9013997B2 (en) * 2012-06-01 2015-04-21 Broadcom Corporation System for performing distributed data cut-through

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW365602B (en) * 1994-06-10 1999-08-01 Rhone Poulenc Rorer Sa New farnesyl transferase inhibitors, their preparation and the pharmaceutical compositions which contain them
WO1996021456A1 (en) * 1995-01-12 1996-07-18 University Of Pittsburgh Inhibitors of prenyl transferases
US5631280A (en) * 1995-03-29 1997-05-20 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase

Also Published As

Publication number Publication date
GB2323842A (en) 1998-10-07
GB2323842A8 (en) 1998-10-26
WO1998045266A1 (en) 1998-10-15
GB9706923D0 (en) 1997-05-21

Similar Documents

Publication Publication Date Title
PL344977A1 (en) Therapeutic uses of quinoline derivatives
AU3548795A (en) Benzopyranopyrazolyl derivatives for the treatment of inflammation
AU1041599A (en) Therapeutic uses of triazolo-pyridazine derivatives
AU3039995A (en) Heterocyclic derivatives of N-phenylamides
AU1925895A (en) 2-chloro and 2-bromo derivatives of 1,5-iminosugars
AU9016898A (en) Methods and compositions for treatment of restenosis
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
AUPQ201499A0 (en) Treatment of inflammatory and malignant diseases
AU6927298A (en) Aminopyridine derivatives for inflammatory and malignant diseases
AU3075595A (en) Anti-helicobacter heterocyclic derivatives of azolones
ZA96452B (en) Dematological use of vitamin d derivatives
HUP0000785A3 (en) Ointment for the treatment of burns and other skin diseases
AU9278598A (en) Use of azole derivatives for the treatment of inflammatory skin conditions
AU4787593A (en) Heterocyclic derivatives useful in the treatment of cardiovascular diseases
AU6927198A (en) 3-aminopyridine derivatives for treatment of inflammatory and malignant diseases
AU6777596A (en) Treatment of human prostate disease with beta-lapachone derivatives
AU8869098A (en) Preparation of pyridine derivatives
AU1870295A (en) Novel derivatives of tetramethylcyclopropane
AU8049098A (en) Composition and methods for the treatment of inflammatory diseases
AU1405001A (en) Treatment of diseases
AU2612295A (en) Enzymatic treatment of soy
AU9082798A (en) Treatment of inflammatory conditions
AU5778698A (en) Reduction of restenosis
AU2595297A (en) Use of aminoalkylcarboxylic derivatives
AU4596097A (en) Improved therapeutic uses of 4-quinoline-carboxylic acid derivatives